Filing status
- Accounts due
- 30 December 2026
- Last accounts
- 31 March 2025
- Conf. stmt due
- 14 April 2027
- Last conf. stmt
- 31 March 2026
Quadrant Pharmaceuticals Limited
- Incorporated
- 14 September 2003 (23 years)
- Industry
- Other business support service activities n.e.c. (82990)
- Directors
- Owned by
- Accounts type
- Small
- Region
- North West
- Address
- Lynstock House Lynstock WayLostockBoltonBL6 4SA
Charges
- Total
- 2
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 1
Officers 2 active
Officer details are public data from the Companies House register.
British
Born January 1955 (71)
Corporate Director · Appointed 7 January 2019
Officer history (18 former)
2 January 2024
21 December 2023
9 February 2023
31 January 2023
17 June 2022
17 June 2022
17 June 2022
Resigned Fishwick, Craig Bernard as Secretary
16 December 2020
Resigned Makan Investments Limited as Corporate Director
7 January 2019
7 January 2019
10 June 2016
Appointed Fishwick, Craig Bernard as Secretary
10 June 2016
10 June 2016
10 June 2016
Resigned Dodgson, John Antony Paul as Secretary
31 December 2015
31 December 2015
Resigned Patel, Manisha as Director
31 December 2015
31 December 2015
8 July 2013
8 July 2013
Appointed Dodgson, John Antony Paul as Secretary
11 January 2012
Appointed Patel, Manisha as Director
1 December 2011
1 December 2011
1 December 2011
1 December 2011
1 December 2011
1 December 2011
1 December 2011
22 May 2006
22 May 2006
10 October 2003
10 October 2003
10 October 2003
Appointed Makan Investments Limited as Corporate Director
10 October 2003
10 October 2003
10 October 2003
14 September 2003
14 September 2003
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 4450328
Group structure 7 shown
Ownership group derived from the Companies House PSC register
Eaststone Limited Owns 75–100% of shares
Maxearn Limited Owns 75–100% of shares
Medihealth Limited Owns 75–100% of shares
Falconline Limited Owns 75–100% of shares
Medihealth International Limited Owns 75–100% of shares
Quadrant Pharmaceuticals Limited This company Owns 75–100% of shares
Financials
Balance sheet as at 31 March 2025 · small accounts
- Cash
- £4,679
- Current Ratio
- 0.4x
Trend
Cash
Balance sheet detail
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Current Assets | £188,869 | £247,170 | £109,131 |
| Debtors | £184,190 | £246,772 | £108,404 |
| Cash | £4,679 | £398 | £727 |
| Creditors (< 1 year) | £492,917 | £546,856 | £373,875 |
| Net Current Assets | (£304,048) | (£299,686) | (£264,744) |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
Doncaster
Milton Keynes
London
London
Houghton Le Spring
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →